Expand MRK Menu
MRK MENU

MRK Latest Press Releases

-- April 15, 2025 --

April 14, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MRK Globe Newswire 1:09 PM

-- April 14, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK PRNewswire 4:14 PM
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm Business Wire 12:22 PM
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. Business Wire 10:18 AM

-- April 13, 2025 --

MRK Investors Have Final Opportunity Today to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 11:55 PM
MRK Deadline Tomorrow: MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PRNewswire 1:38 PM
MRK Investors Have the Opportunity to Lead the Merck Securities Fraud Lawsuit with Faruqi & Faruqi, LLP Globe Newswire 8:23 AM

-- April 12, 2025 --

MRK DEADLINE MONDAY: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - MRK Globe Newswire 11:11 AM

-- April 11, 2025 --

Deadline Soon: Merck & Co (MRK) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit Business Wire 12:00 PM
Investors who lost money on Merck & Co., Inc.(MRK) should contact Levi & Korsinsky about pending Class Action - MRK PRNewswire 5:45 AM

-- April 10, 2025 --

Merck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. April 14, 2025 Deadline to file Lead Plaintiff Motion Globe Newswire 6:46 PM
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors - Contact Levi & Korsinsky Globe Newswire 12:56 PM
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 12:00 PM
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. PRNewswire 9:47 AM
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck & Co., Inc. Lawsuit - MRK PRNewswire 5:45 AM

-- April 9, 2025 --

MRK FINAL DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action - MRK Globe Newswire 4:59 PM
Investors who lost money on Merck & Co., Inc. (MRK) should contact The Gross Law Firm about pending Class Action - MRK Globe Newswire 12:35 PM
Deadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit Globe Newswire 12:00 PM
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. Globe Newswire 10:44 AM

-- April 8, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK PRNewswire 10:00 AM
Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc.(MRK) PRNewswire 5:45 AM

-- April 7, 2025 --

MRK Deadline: MRK Purchasers with Losses in Excess of $100K Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PRNewswire 3:55 PM
MRK FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important April 14 Deadline in Securities Class Action - MRK Globe Newswire 3:24 PM
Merck & Co., Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - MRK Globe Newswire 1:46 PM
Shareholders that lost money on Merck & Co., Inc.(MRK) should contact The Gross Law Firm about pending Class Action - MRK PRNewswire 5:45 AM

-- April 6, 2025 --

Faruqi & Faruqi Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK Globe Newswire 10:05 AM

-- April 5, 2025 --

MRK DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - MRK Globe Newswire 8:17 AM

-- April 4, 2025 --

MRK Investors Have Opportunity to Lead Merck Securities Fraud Lawsuit with Faruqi & Faruqi, LLP PRNewswire 4:35 PM
Investors who lost money on Merck & Co., Inc.(MRK) should contact Levi & Korsinsky about pending Class Action - MRK Globe Newswire 1:43 PM
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 12:00 PM
Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact Levi & Korsinsky PRNewswire 5:45 AM

-- April 3, 2025 --

Merck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; April 14, 2025 Deadline to file Lead Plaintiff Motion Globe Newswire 4:13 PM
Shareholders of Merck & Co., Inc. Should Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights - MRK Globe Newswire 1:05 PM
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors - Contact The Gross Law Firm PRNewswire 5:45 AM

-- April 2, 2025 --

MRK Deadline: MRK Purchasers with Losses in Excess of $100K Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PRNewswire 4:04 PM
MRK DEADLINE ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Merck & Co., Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - MRK Globe Newswire 3:17 PM
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 12:00 PM
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. Globe Newswire 9:55 AM
MRK Investors Have Final Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 9:13 AM

-- April 1, 2025 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, TransMedics, Intellia, and Merck and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit - MRK Globe Newswire 1:31 PM
MERCK & CO., INC. (NYSE: MRK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Merck & Co., Inc. Investors of Upcoming Deadline Globe Newswire 7:15 AM
Merck to Hold First-Quarter 2025 Sales and Earnings Conference Call April 24 Business Wire 6:45 AM
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors - Contact Levi & Korsinsky PRNewswire 5:45 AM

-- March 31, 2025 --

Merck & Co., Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights - MRK Globe Newswire 1:13 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK PRNewswire 12:43 PM
Deadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit Globe Newswire 12:00 PM
WINREVAIR (sotatercept-csrk) Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76% Compared to Placebo in the Phase 3 ZENITH Trial Business Wire 10:00 AM
Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm PRNewswire 5:45 AM

-- March 30, 2025 --

ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK Globe Newswire 8:42 AM
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. Globe Newswire 7:03 AM

-- March 28, 2025 --

MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PRNewswire 5:39 PM
Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky PRNewswire 5:45 AM

-- March 27, 2025 --

Merck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. April 14, 2025 Deadline to file Lead Plaintiff Motion. Globe Newswire 7:52 PM
Investors who lost money on Merck & Co., Inc. (MRK) should contact Levi & Korsinsky about pending Class Action - MRK Globe Newswire 12:53 PM
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK Globe Newswire 12:50 PM
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 12:00 PM
Merck's Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous (IV) KEYTRUDA (pembrolizumab) in Pivotal 3475A-D77 Trial Business Wire 11:01 AM
Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact The Gross Law Firm PRNewswire 5:45 AM

-- March 26, 2025 --

Faruqi & Faruqi Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK Globe Newswire 3:31 PM
DEADLINE ALERT for ESTC, MRK, and FMC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire 12:13 PM
DEADLINE ALERT for ICLR, ESTC, FMC, MRK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions Globe Newswire 12:00 PM
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc. (MRK) Shareholders Globe Newswire 11:13 AM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK Globe Newswire 8:00 AM
European Commission (EC) Approves Merck's CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults Business Wire 6:45 AM

-- March 25, 2025 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, TransMedics, Alarum, and Merck and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK PRNewswire 10:00 AM
MRK Investors Have Final Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 9:42 AM
Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Business Wire 6:45 AM

-- March 24, 2025 --

Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK) Globe Newswire 1:49 PM
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. Business Wire 12:43 PM
MERCK & CO., INC. (NYSE: MRK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Merck & Co., Inc. Investors of Upcoming Deadline Globe Newswire 12:15 PM
MRK LAWSUIT ALERT: The Gross Law Firm Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PRNewswire 5:45 AM

-- March 23, 2025 --

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. Globe Newswire 8:46 AM

-- March 22, 2025 --

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. PRNewswire 7:53 AM

-- March 21, 2025 --

Levi & Korsinsky Notifies Shareholders of Merck & Co., Inc. (MRK) of a Class Action Lawsuit and an Upcoming Deadline Globe Newswire 1:37 PM
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 12:00 PM
Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRK PRNewswire 5:45 AM

-- March 20, 2025 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, TransMedics, Alarum, and Merck and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PRNewswire 6:24 PM
The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 MRK Globe Newswire 1:01 PM
Shareholders of Merck & Co., Inc. Should Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights - MRK PRNewswire 5:04 AM

-- March 19, 2025 --

Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 12:00 PM
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. Globe Newswire 11:23 AM
Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease Business Wire 6:45 AM

-- March 18, 2025 --

Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join Contact Levi & Korsinsky Globe Newswire 1:21 PM
DEADLINE ALERT for ESTC, MRK, and FMC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire 12:09 PM
Deadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit Globe Newswire 12:00 PM
Levi & Korsinsky Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK PRNewswire 5:45 AM

-- March 17, 2025 --

MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PRNewswire 6:56 PM
Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class Action Contact The Gross Law Firm to Learn More Globe Newswire 2:34 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK PRNewswire 1:41 PM
Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact The Gross Law Firm PRNewswire 5:45 AM
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 3:34 AM

-- March 15, 2025 --

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. Globe Newswire 8:37 AM

-- March 13, 2025 --

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRK Globe Newswire 6:59 PM
Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 4:05 PM
Contact Levi & Korsinsky by April 14, 2025 Deadline to Join Class Action Against Merck & Co., Inc. (MRK) Globe Newswire 1:02 PM
Merck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK PRNewswire 5:45 AM

-- March 12, 2025 --

DEADLINE ALERT for ICLR, ESTC, FMC, MRK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions Globe Newswire 1:13 PM
Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48 Business Wire 11:26 AM
Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact Levi & Korsinsky PRNewswire 5:44 AM

-- March 11, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK PRNewswire 1:41 PM
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. Globe Newswire 10:09 AM
Merck Unveils New Facility to Increase Vaccine Production Capacity Business Wire 6:45 AM

-- March 10, 2025 --

ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRK Globe Newswire 6:23 PM
Levi & Korsinsky Reminds Merck & Co., Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 MRK Globe Newswire 1:11 PM
MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PRNewswire 12:45 PM
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 10:11 AM
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc.(MRK) Shareholders PRNewswire 5:45 AM

-- March 8, 2025 --

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. Globe Newswire 7:52 AM

-- March 7, 2025 --

Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 12:00 PM
Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRK PRNewswire 5:46 AM

-- March 6, 2025 --

The Gross Law Firm Reminds Merck & Co., Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 MRK Globe Newswire 12:17 PM
DEADLINE ALERT for ESTC, MRK, and FMC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire 12:07 PM
Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRK PRNewswire 5:45 AM

-- March 5, 2025 --

Merck & Co (MRK) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PRNewswire 12:00 PM

-- March 4, 2025 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, Elastic, Intellia, and Merck and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
ROSEN, A LEADING NATIONAL FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRK Globe Newswire 7:57 PM
Shareholders that lost money on Merck & Co., Inc.(MRK) should contact Levi & Korsinsky about pending Class Action - MRK Globe Newswire 12:31 PM
Class Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors - Contact Levi & Korsinsky PRNewswire 5:45 AM

-- March 3, 2025 --

Investors in Merck & Co., Inc. Should Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights MRK Globe Newswire 1:20 PM
MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PRNewswire 1:10 PM
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK PRNewswire 12:50 PM
Deadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit Globe Newswire 12:00 PM
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 9:54 AM
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit - MRK PRNewswire 5:45 AM

-- March 1, 2025 --

ROSEN, A LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRK Globe Newswire 1:14 PM

-- February 28, 2025 --

Deadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit Business Wire 12:00 PM
MRK LAWSUIT ALERT: Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline PRNewswire 5:45 AM

-- February 27, 2025 --

Merck & Co., Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; April 14, 2025 Deadline to file Lead Plaintiff Motion Globe Newswire 3:53 PM
MRK LAWSUIT ALERT: Levi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline Globe Newswire 12:44 PM
Deadline Approaching: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith Business Wire 12:00 PM
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. PRNewswire 9:33 AM
Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PRNewswire 5:45 AM

-- February 26, 2025 --

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRK Globe Newswire 7:00 PM
MERCK INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MRK Globe Newswire 5:10 PM
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc. (MRK) Shareholders Globe Newswire 1:33 PM
DEADLINE ALERT for ICLR, ESTC, FMC, MRK: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions Globe Newswire 12:00 PM

-- February 25, 2025 --

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Edison, Elastic, Intellia, and Merck and Encourages Investors to Contact the Firm Globe Newswire 9:00 PM
MRK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Business Wire 4:00 PM
Law Offices of Frank R. Cruz Encourages Merck & Co (MRK) Investors to Inquire About Securities Fraud Class Action Business Wire 12:07 PM
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm PRNewswire 7:06 AM
MERCK & CO., INC. (NYSE: MRK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Merck & Co., Inc. Investors of Upcoming Deadline Globe Newswire 7:00 AM
FDA Grants Priority Review to Merck's Application for KEYTRUDA (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma Business Wire 6:45 AM
Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact Levi & Korsinsky PRNewswire 5:45 AM

-- February 24, 2025 --

MRK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PRNewswire 4:00 PM
Shareholders of Merck & Co., Inc. Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights MRK Globe Newswire 12:22 PM
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Merck & Co (MRK) Investors To Inquire About Securities Fraud Class Action Business Wire 12:00 PM
Merck to Participate in the TD Cowen 45th Annual Health Care Conference Business Wire 6:45 AM
The Gross Law Firm Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRK PRNewswire 5:45 AM
MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PRNewswire 3:40 AM

-- February 23, 2025 --

ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRK Globe Newswire 10:54 PM

-- February 22, 2025 --

MERCK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MRK Globe Newswire 5:15 PM

-- February 21, 2025 --

DEADLINE ALERT for ESTC, MRK, and FMC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Globe Newswire 12:06 PM
Law Offices of Howard G. Smith Encourages Merck & Co (MRK) Investors To Inquire About Securities Fraud Class Action Business Wire 12:00 PM
INVESTOR ALERT: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MRK PRNewswire 9:00 AM
Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - MRK PRNewswire 5:45 AM

-- February 20, 2025 --

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRK Globe Newswire 4:50 PM
Securities Fraud Investigation Into Merck & Co (MRK) Announced Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Business Wire 3:00 PM
Shareholders that lost money on Merck & Co., Inc.(MRK) should contact The Gross Law Firm about pending Class Action - MRK Globe Newswire 1:32 PM
Merck & Co (MRK) Investors Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation Business Wire 1:05 PM
MRK INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In MRK To Contact Him Directly To Discuss Their Options PRNewswire 10:51 AM
Merck & Co., Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights - MRK PRNewswire 5:45 AM

-- February 19, 2025 --

Securities Fraud Investigation Into Merck & Co (MRK) Announced Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz Business Wire 9:00 PM
MERCK & CO., INC. (NYSE: MRK) INVESTOR ALERT: Investors With Large Losses in Merck & Co., Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights Globe Newswire 1:50 PM
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. Globe Newswire 10:04 AM

-- February 18, 2025 --

Merck & Co. Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Filed Against MRK Globe Newswire 8:09 PM
MRK INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Globe Newswire 4:30 PM
MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PRNewswire 2:53 PM
Investors in Merck & Co., Inc. Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights MRK Globe Newswire 2:27 PM
GeminiBio Appoints Mike Stella to Board Business Wire 9:00 AM
WELIREG (belzutifan) Receives First European Commission Approval for Two Indications Business Wire 6:45 AM
Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRK PRNewswire 5:45 AM

-- February 17, 2025 --

MRK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Business Wire 4:00 PM
MRK INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Business Wire 5:40 AM

-- February 16, 2025 --

MRK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PRNewswire 4:00 PM

-- February 15, 2025 --

MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm Business Wire 12:19 PM
MRK INVESTOR NOTICE: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PRNewswire 9:36 AM

-- February 14, 2025 --

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action MRK Globe Newswire 3:43 PM
MRK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Business Wire 9:15 AM
Investor Alert: Robbins LLP Informs Stockholders of the Merck & Co., Inc. Class Action PRNewswire 12:45 AM

-- February 13, 2025 --

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Merck & Co., Inc. (MRK) Globe Newswire 4:29 PM
MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit PRNewswire 3:57 PM
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co. Globe Newswire 1:31 PM
Rosen Law Firm Urges Merck & Co., Inc. (NYSE: MRK) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights Business Wire 1:07 PM
MRK INVESTOR ALERT: Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PRNewswire 6:10 AM

-- February 12, 2025 --

MRK INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead the Merck Class Action Lawsuit Globe Newswire 6:31 PM
Rosen Law Firm Encourages Merck & Co. Inc. Investors to Inquire About Securities Class Action Investigation MRK Business Wire 5:38 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Merck & Co., Inc. Securities and Sets a Lead Plaintiff Deadline of April 14, 2025 Globe Newswire 5:00 PM

-- February 6, 2025 --

Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma Business Wire 6:45 AM

-- February 4, 2025 --

Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results Business Wire 6:30 AM

-- January 31, 2025 --

Merck Receives Positive EU CHMP Opinion for CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults Business Wire 6:45 AM

-- January 30, 2025 --

Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR (sotatercept-csrk) Early and Move to Final Analysis Business Wire 6:45 AM

-- January 28, 2025 --

Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization Business Wire 1:28 PM

-- January 27, 2025 --

FDA Grants Priority Review to Merck's Application for WELIREG (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL) Business Wire 6:45 AM

-- January 24, 2025 --

Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Evaluating KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) in Combination with Chemotherapy in Patients with Certain Types of Gastroesophageal Adenocarcinoma Business Wire 6:45 AM

-- January 16, 2025 --

Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4 Business Wire 6:45 AM

-- January 13, 2025 --

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments Yolowire 9:18 AM

-- January 8, 2025 --

Merck's GARDASIL Receives Expanded Approval for Males in China Business Wire 6:48 AM

-- January 6, 2025 --

Merck to Participate in the 43rd Annual J.P. Morgan Healthcare Conference Business Wire 6:45 AM

-- December 20, 2024 --

Merck Closes Exclusive Global License Agreement for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody Business Wire 6:45 AM

-- December 19, 2024 --

Merck Announces Topline Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) for the Treatment of Adults with Virologically Suppressed HIV-1 Infection Business Wire 6:45 AM

-- December 18, 2024 --

Merck Enters into Exclusive Global License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist Business Wire 6:45 AM

-- December 17, 2024 --

Merck Announces FDA Acceptance of Biologics License Application for Clesrovimab, an Investigational Long-Acting Monoclonal Antibody Designed to Protect Infants from RSV Disease During their First RSV Season Business Wire 6:45 AM

-- December 16, 2024 --

Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab Business Wire 4:30 PM
Merck's KEYTRUDA (pembrolizumab) Approved in China in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy After Surgery as Adjuvant Treatment for Patients With Resectable Stage II, IIIA or IIIB NSCLC Business Wire 6:45 AM

-- December 13, 2024 --

Merck Receives Positive EU CHMP Opinion for WELIREG (belzutifan) as Treatment for Adult Patients With Certain Types of Von Hippel-Lindau Disease-Associated Tumors and for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma Business Wire 7:05 AM

-- December 11, 2024 --

LYNPARZA (olaparib) Demonstrated Clinically Meaningful Prolonged Survival Benefit in Early Breast Cancer in OlympiA Phase 3 Trial Business Wire 10:22 AM

-- December 9, 2024 --

Merck Announces Phase 3 KEYLYNK-001 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Advanced Epithelial Ovarian Cancer Business Wire 6:45 AM

-- December 8, 2024 --

Merck's Investigational Zilovertamab Vedotin in Combination With R-CHP Demonstrates Complete Response Rate of 100% at 1.75 mg/kg Dose in Phase 2 Trial of Previously Untreated Patients With Diffuse Large B-Cell Lymphoma Business Wire 3:00 PM

-- December 5, 2024 --

Merck and Ridgeback Biotherapeutics Announce Initiation of Phase 3 Study (MOVe-NOW) Evaluating LAGEVRIO (molnupiravir) for the Treatment of COVID-19 in High-Risk Adults Business Wire 6:45 AM

-- December 3, 2024 --

FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan (sac-TMT) for the Treatment of Certain Patients With Previously Treated Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer With EGFR Mutations Business Wire 6:45 AM

-- November 26, 2024 --

Merck to Participate in the Citi 2024 Global Healthcare Conference Business Wire 6:45 AM

-- November 25, 2024 --

Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR (sotatercept-csrk) Met Primary Endpoint at Interim Analysis Business Wire 6:45 AM

-- November 22, 2024 --

Merck Recommends Rejection of TRC Capital's "Mini-Tender" Offer Business Wire 4:17 PM
Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference Business Wire 7:15 AM
Merck's WELIREG (belzutifan) Approved in China for the Treatment of Adult Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors Business Wire 6:45 AM
Surendralal Karsanbhai Elected to Merck Board of Directors Business Wire 6:30 AM

-- November 21, 2024 --

Merck Data at the ASH 2024 Annual Meeting Highlights Promising Hematology Pipeline With Diverse Range of Investigational Assets and Novel Modalities Business Wire 6:45 AM

-- November 19, 2024 --

Merck Announces First-Quarter 2025 Dividend Business Wire 12:22 PM
Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints Business Wire 6:45 AM

-- November 15, 2024 --

Merck Receives Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Adult Patients With Unresectable Non-Epithelioid Malignant Pleural Mesothelioma (MPM) Business Wire 7:15 AM